Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. 2002

Takuya Yamamoto, and Shinya Omoto, and Masaaki Mizuguchi, and Hajime Mizukami, and Harumi Okuyama, and Noriko Okada, and Nitin K Saksena, and Ebiamadon A Brisibe, and Kaori Otake, and Yoichi R Fuji
Division of Nutritional Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi 467-8603, Japan.

RNA interference (RNAi) has been reported to be post-transcriptional gene silencing (PTGS) by approximately 500 nucleotide-(nt)-long double-stranded (ds) RNA that specifically targets homologous sequences of messenger RNA. In this report, we describe inhibition of HIV-1 transcription by synthetic dsRNAs constructed with mutated nef genes (nef dsRNAs) derived from long-term non-progressors (LTNPs) using cotransfection of the target gene-expressing plasmid and dsRNA. The effects of nef dsRNAs were examined with luciferase (Luc) reporter which is combined with the HIV-1 (SF2) LTR in persistently HIV-1-infected T cell and macrophage cell lines. At 48 hr, a defective nef dsRNA (556 nt) suppressed Luc activity more potently than did SF2 full-length nef dsRNA (744 nt), suggesting that approximately 500 nt-long nef dsRNA could interfere with the HIV-1 transcription.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012330 RNA, Double-Stranded RNA consisting of two strands as opposed to the more prevalent single-stranded RNA. Most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms. Double-Stranded RNA,Double Stranded RNA,RNA, Double Stranded
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015693 Gene Products, nef Products of the retroviral NEF GENE. They play a role as accessory proteins that influence the rate of viral infectivity and the destruction of the host immune system. nef gene products were originally found as factors that trans-suppress viral replication and function as negative regulators of transcription. nef stands for negative factor. nef Gene Products,nef Protein,3'-orf Protein,Gene Product, nef,3' orf Protein,nef Gene Product
D054311 nef Gene Products, Human Immunodeficiency Virus Proteins encoded by the NEF GENES of the HUMAN IMMUNODEFICIENCY VIRUS. nef Protein, Human Immunodeficiency Virus,HIV-3'-orf Protein,nef Protein, HIV,HIV 3' orf Protein,HIV nef Protein
D020276 HIV Long-Term Survivors Persons who have experienced prolonged survival of HIV infection. This includes the full spectrum of untreated, HIV-infected long-term asymptomatics to those with AIDS who have survived due to successful treatment. AIDS Long-Term Survivors,Long-Term Survivors, HIV,HIV-1 Long-Term Survivors,AIDS Long Term Survivors,AIDS Long-Term Survivor,HIV 1 Long Term Survivors,HIV Long Term Survivors,HIV Long-Term Survivor,HIV-1 Long-Term Survivor,Long Term Survivors, HIV,Long-Term Survivor, AIDS,Long-Term Survivor, HIV,Long-Term Survivor, HIV-1,Long-Term Survivors, AIDS,Long-Term Survivors, HIV-1
D034622 RNA Interference A gene silencing phenomenon whereby specific dsRNAs (RNA, DOUBLE-STRANDED) trigger the degradation of homologous mRNA (RNA, MESSENGER). The specific dsRNAs are processed into SMALL INTERFERING RNA (siRNA) which serves as a guide for cleavage of the homologous mRNA in the RNA-INDUCED SILENCING COMPLEX. DNA METHYLATION may also be triggered during this process. Gene Silencing, Post-Transcriptional,Post-Transcriptional Gene Silencing,Co-Suppression,Cosuppression,Posttranscriptional Gene Silencing,RNA Silencing,RNAi,Co Suppression,Gene Silencing, Post Transcriptional,Gene Silencing, Posttranscriptional,Gene Silencings, Posttranscriptional,Interference, RNA,Post Transcriptional Gene Silencing,Post-Transcriptional Gene Silencings,Silencing, Post-Transcriptional Gene

Related Publications

Takuya Yamamoto, and Shinya Omoto, and Masaaki Mizuguchi, and Hajime Mizukami, and Harumi Okuyama, and Noriko Okada, and Nitin K Saksena, and Ebiamadon A Brisibe, and Kaori Otake, and Yoichi R Fuji
February 1992, Proceedings of the National Academy of Sciences of the United States of America,
Takuya Yamamoto, and Shinya Omoto, and Masaaki Mizuguchi, and Hajime Mizukami, and Harumi Okuyama, and Noriko Okada, and Nitin K Saksena, and Ebiamadon A Brisibe, and Kaori Otake, and Yoichi R Fuji
May 1996, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
Takuya Yamamoto, and Shinya Omoto, and Masaaki Mizuguchi, and Hajime Mizukami, and Harumi Okuyama, and Noriko Okada, and Nitin K Saksena, and Ebiamadon A Brisibe, and Kaori Otake, and Yoichi R Fuji
May 1993, Virology,
Takuya Yamamoto, and Shinya Omoto, and Masaaki Mizuguchi, and Hajime Mizukami, and Harumi Okuyama, and Noriko Okada, and Nitin K Saksena, and Ebiamadon A Brisibe, and Kaori Otake, and Yoichi R Fuji
November 2008, Journal of virology,
Takuya Yamamoto, and Shinya Omoto, and Masaaki Mizuguchi, and Hajime Mizukami, and Harumi Okuyama, and Noriko Okada, and Nitin K Saksena, and Ebiamadon A Brisibe, and Kaori Otake, and Yoichi R Fuji
May 2004, Journal of virology,
Takuya Yamamoto, and Shinya Omoto, and Masaaki Mizuguchi, and Hajime Mizukami, and Harumi Okuyama, and Noriko Okada, and Nitin K Saksena, and Ebiamadon A Brisibe, and Kaori Otake, and Yoichi R Fuji
June 1994, Journal of virology,
Takuya Yamamoto, and Shinya Omoto, and Masaaki Mizuguchi, and Hajime Mizukami, and Harumi Okuyama, and Noriko Okada, and Nitin K Saksena, and Ebiamadon A Brisibe, and Kaori Otake, and Yoichi R Fuji
June 2004, The Journal of general virology,
Takuya Yamamoto, and Shinya Omoto, and Masaaki Mizuguchi, and Hajime Mizukami, and Harumi Okuyama, and Noriko Okada, and Nitin K Saksena, and Ebiamadon A Brisibe, and Kaori Otake, and Yoichi R Fuji
April 2001, Journal of virology,
Takuya Yamamoto, and Shinya Omoto, and Masaaki Mizuguchi, and Hajime Mizukami, and Harumi Okuyama, and Noriko Okada, and Nitin K Saksena, and Ebiamadon A Brisibe, and Kaori Otake, and Yoichi R Fuji
February 1993, The Journal of biological chemistry,
Takuya Yamamoto, and Shinya Omoto, and Masaaki Mizuguchi, and Hajime Mizukami, and Harumi Okuyama, and Noriko Okada, and Nitin K Saksena, and Ebiamadon A Brisibe, and Kaori Otake, and Yoichi R Fuji
October 1999, Journal of virology,
Copied contents to your clipboard!